Healthcare resource utilization, healthcare costs and dose escalation in psoriasis patients initiated on ustekinumab versus adalimumab: a retrospective claim study-Reference-Cited by-同舟云学术

Healthcare resource utilization, healthcare costs and dose escalation in psoriasis patients initiated on ustekinumab versus adalimumab: a retrospective claim study

Published:2016-11-15 Issue:4 Volume:28 Page:290-298
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Wu Jashin J.¹,Guérin Annie²,Gauthier Geneviève²,Sundaram Murali³

Affiliation:

1. Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA;

2. Analysis Group, Inc, Montreal, QC, Canada;

3. Health Economics and Outcomes Research, AbbVie, North Chicago, IL, USA

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2016.1247946

Reference18 articles.

1. British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009

2. European S3-Guidelines on the systemic treatment of psoriasis vulgaris

3. Guidelines of care for the management of psoriasis and psoriatic arthritis

4. Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose escalation of biologic treatment in patients with moderate‐to‐severe psoriasis in Japan;Experimental Dermatology;2024-05

2. Drug Survival of Adalimumab, Secukinumab, and Ustekinumab in Psoriasis as Determined by Either Dose Escalation or Drug Discontinuation during the First 3 Years of Treatment – a Nationwide Cohort Study;Journal of Investigative Dermatology;2023-11

3. Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settings;Journal of Medical Economics;2022-06-06

4. Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review;Dermatology and Therapy;2021-06-03

5. Reduced doses of biological therapies in psoriasis may increase efficiency without decreasing drug survival;Dermatologic Therapy;2020-09-07